The global anatomic pathology market is witnessing substantial growth, with a valuation of US$ 32.5 Million in 2022 and a projected robust CAGR of 8.2% from 2022 to 2030. By the end of the decade, the market is anticipated to surpass US$ 61.1 Million. Future Market Insights leader, is strategically positioned to capitalize on this accelerating trend.
The upward trajectory in the anatomic pathology market is attributed to the increasing application of anatomic pathology in disease diagnosis and the dynamic field of drug discovery and development. Future Market Insights is at the forefront of innovation, leveraging cutting-edge technology and a commitment to excellence to meet the evolving demands of the healthcare and pharmaceutical sectors.
To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-12370
As a key player in the market, Future Market Insights is well-poised to play a pivotal role in advancing anatomic pathology solutions. With a strong focus on quality, accuracy, and efficiency, Future Market Insights is dedicated to providing state-of-the-art diagnostic tools and services that contribute to enhanced patient outcomes and accelerate drug development processes.
“We are thrilled to witness the remarkable growth in the global anatomic pathology market, and Future Market Insights is committed to driving innovation and delivering unparalleled solutions to meet the evolving needs of healthcare professionals and researchers worldwide,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).
Key Takeaways:
- The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030
- Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents
- Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination
- Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers
In Case Of Any Queries, Don’t Hesitate To Contact Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-12370
Key Participant Insights:
The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.
For instance:
- In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
- In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
- In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.
Key companies profiled:
- Laboratory Corporation of America Holdings
- Sakura Finetek USA, Inc.
- F.Hoffmann-La Roche AG
- Cardinal Health, Inc.
- BioGenex
- NeoGenomics
- Agilent Technologies
The US continues to be one of the leading markets for anatomic pathology industry globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology industry during the assessment period.
The Europe anatomic pathology industry is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.
Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.
Personalized Experiences Redefined: Our Customization Report Holds the Answers! https://www.futuremarketinsights.com/customization-available/rep-gb-12370
Key Segments of Anatomic Pathology Industry Survey:
Anatomic Pathology Industry by Product & Service:
- Anatomic Pathology Instruments
- Anatomic Pathology Consumables
- Anatomic Pathology Services
Anatomic Pathology Industry by Application:
- Disease Diagnosis
- Drug Discovery and Development
- Others
Anatomic Pathology Industry by End User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Anatomic Pathology Industry by Region:
- North America Anatomic Pathology Industry
- Latin America Anatomic Pathology Industry
- Europe Anatomic Pathology Industry
- East Asia Anatomic Pathology Industry
- South Asia & Pacific Anatomic Pathology Industry
- Middle East & Africa (MEA) Anatomic Pathology Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube